ArticleJAMA network open2024

Clinical Outcomes of Tirzepatide or GLP-1 Receptor Agonists in Individuals With Type 2 Diabetes.

Min-Hsiang Chuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.